Two-Way Clinical Messaging in a CML Specialty Pharmacy Service Model

Autor: Surya C. Singh, Christine Sawicki, Jennifer M. Polinski, Ruchik Patel, Kayla E Friend

Publikováno v: Journal of managed carespecialty pharmacy. 25(11)

Adherence to treatment is correlated with treatment success in chronic myeloid leukemia (CML). CVS Specialty explored novel methods to improve adherence in this population to ensure optimal adherence and lower the risk of unsuccessful treatment. One

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b1cb4e5e5900485d2a24fc043ce431
https://pubmed.ncbi.nlm.nih.gov/31663460

Biosimilar Competition In The United States: Statutory Incentives, Payers, And Pharmacy Benefit Managers

Autor: Troyen A. Brennan, Surya C. Singh, Benjamin P. Falit

Publikováno v: Health Affairs. 34:294-301

Widespread adoption of generic medications, made possible by the Hatch-Waxman Act of 1984, has contained the cost of small-molecule drugs in the United States. Biologics, however, have yet to face competition from follow-on products and represent the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e392b685391996699158e7c291018890
https://doi.org/10.1377/hlthaff.2014.0482

Specialty medications: traditional and novel tools can address rising spending on these costly drugs

Autor: Troyen A. Brennan, Benjamin P. Falit, Alan M. Lotvin, William H. Shrank, Surya C. Singh

Publikováno v: Health affairs (Project Hope). 33(10)

Spending on specialty medications, which represented a small proportion of US pharmacy spending at the beginning of this decade, is growing by more than 15 percent annually. It is expected to account for approximately half ($235 billion) of total ann

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f131d9b0197b9214675d92450baba75
https://pubmed.ncbi.nlm.nih.gov/25288417

Specialty medications: traditional and novel tools can address rising spending on these costly drugs.

Autor: Lotvin AM; Alan M. Lotvin is executive vice president for specialty pharmacy at CVS Caremark, in Woonsocket, Rhode Island., Shrank WH; William H. Shrank (william.shrank@cvscaremark.com) is chief scientific officer and chief medical officer of provider innovation at CVS Caremark., Singh SC; Surya C. Singh is corporate vice president for specialty client solutions and trend management at CVS Caremark., Falit BP; Benjamin P. Falit is a resident physician in the Harvard Radiation Oncology Program at Brigham and Women's Hospital, in Boston, Massachusetts, and a consultant to CVS Caremark on matters related to oncology and specialty pharmacy strategy., Brennan TA; Troyen A. Brennan is chief medical officer at CVS Caremark.

Publikováno v: Health affairs (Project Hope) [Health Aff (Millwood)] 2014 Oct; Vol. 33 (10), pp. 1736-44.